Charles Nicolle Hospital

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Hepatitis B1 trial
• Lung cancer1 trial
• Multiple sclerosis1 trial

Phase

• Phase 21 trial

Status

• Recruiting2 trials
• Terminated1 trial

Lead sponsor

• ANRS, Emerging Infectious Diseases1 trial
• Innate Pharma1 trial
• Lille Catholic University1 trial

Running trials

• Recruiting

  Remediation Program Via a "Serious Game" for the Cognitive Functions of Multiple Sclerosis Patients

  NCT04694534· Lille Catholic University· Source

  Contact: Bertrand Bourre

• Recruiting

  National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses

  NCT04166266· ANRS, Emerging Infectious Diseases· Source

  Contact: Ghassan RIACHI (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Hepatitis B1 recruiting
• Multiple sclerosis1 recruiting

Closed trials

• Recruiting

  IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)

  NCT05742607· Phase 2· Innate Pharma· Source

  Contact: Innate Pharma